Invivo Therapeutics Holdings Corp.
NVIVDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001292519
Invivo Therapeutics Holdings Corp. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Feb 7, 2024; 14 institutions reported holding it in 13F filings for Q4 2023, worth $68.1K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Invivo Therapeutics Holdings Corp. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 97.2K | 104.3K | +7.08K (+7.3%) |
| Value | $131.0K | $118.5K | −$12.5K (−9.5%) |
New holders (3)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Indiana Trust & Investment Management CO | 2 | $2 | 0.00% |
| Milestone Investment Advisors LLC | 1 | $2 | 0.00% |
| Provenance Wealth Advisors, LLC | 1 | $1 | 0.00% |
Sold out (3)
Institutions that held Invivo Therapeutics Holdings Corp. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| FMR LLC | 73 | $99 |
| TD Waterhouse Canada Inc. | 6 | $11 |
| WealthPLAN Partners, LLC | 1 | $1 |